A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Adefovir Dipivoxil is effective and safe in
treatment of Chinese Patients with HBeAg positive Chronic Hepatitis B for 5 years.